Argenx
ARGX
#534
Rank
C$54.80 B
Marketcap
$896.30
Share price
-0.35%
Change (1 day)
90.53%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - P/B ratio

P/B ratio as of December 2024 : 9.00

According to Argenx 's latest financial reports the company has a price-to-book ratio of 20.6329.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Argenx - P/B ratio (from 2021 to 2020)

P/B ratio by year

Year P/B ratio Change
2024-12-318.6456.92%
2023-12-315.51-26.06%
2022-12-317.452.64%
2021-12-317.266.56%
2020-12-316.8130.91%
2019-12-315.204.53%
2018-12-314.9823.24%
2017-12-314.04
2016-12-31N/A
2015-12-31N/A-100%
2014-12-311.96
2013-12-31N/A